Details of the Drug

General Information of Drug (ID: DMI04GC)

• Drug Name: PMID29473428-Compound-17
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 187.56
  Logarithm of the Partition Coefficient (xlogp); 1.7
  Rotatable Bond Count (rotbonds); 0
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: C6H3ClFN3O
  IUPAC Name: 6-chloro-5-fluoro-[1,2]oxazolo[5,4-b]pyridin-3-amine
  Canonical SMILES: C1=C2C(=NOC2=NC(=C1F)Cl)N
  InChI: InChI=1S/C6H3ClFN3O/c7-4-3(8)1-2-5(9)11-12-6(2)10-4/h1H,(H2,9,11)
  InChIKey: MTIDNIWREKNKHM-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 118867629
  TTD ID: D0XT4V

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Indoleamine 2,3-dioxygenase 1 (IDO1)	TTZJYKH	I23O1_HUMAN	Not Available	[1]

References

• [1] A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330.